SLU-PP-332 FAQ: Sourcing, Purity, Storage & Shipping
This comprehensive SLU-PP-332 FAQ addresses critical technical questions regarding raw material sourcing, analytical purity verification, solvent reconstitution protocols, and lab storage guidelines. Designed for principal investigators and laboratory technicians, PX1 Research provides high-purity research compounds exclusively for in vitro and preclinical investigation.
Quick answer
This comprehensive SLU-PP-332 FAQ addresses critical technical questions regarding raw material sourcing, analytical purity verification, solvent reconstitution protocols, and lab storage guidelines. Designed for principal investigators and laboratory technicians, PX1 Research provides high-purity research compounds exclusively for in vitro and preclinical investigation.
Key takeaways
- Q: What is SLU-PP-332 and how is it classified in laboratory research?
- Q: Where is PX1 Research SLU-PP-332 synthesized?
- Q: How is the purity of SLU-PP-332 verified by PX1 Research?
- Q: Is SLU-PP-332 tested for bacterial endotoxins and residual contaminants?
Chemical Overview and Compliance FAQs
Q: What is SLU-PP-332 and how is it classified in laboratory research? A: SLU-PP-332 is a synthetic small-molecule pan-agonist of the estrogen-related receptors (ERRα, ERRβ, and ERRγ). In preclinical models, it serves as a tool compound to study mitochondrial biogenesis, oxidative phosphorylation, and cellular energy metabolism. It is strictly designated for in vitro cell culture and preclinical animal models.
Q: Is SLU-PP-332 approved for human consumption or therapeutic administration? A: No. SLU-PP-332 is a non-clinical research compound supplied strictly for laboratory research use only. It has not received regulatory approval for therapeutic, diagnostic, or veterinary applications. All handling must adhere to standard laboratory biosafety protocols.
Q: Where can researchers view the complete catalog of PX1 research compounds? A: Investigators evaluating metabolic modulators, mitochondrial peptides, and signaling compounds can explore our full inventory via the all peptides directory, which outlines chemical specifications, molecular weights, and available lot batches.
Sourcing and Manufacturing FAQs
Q: Where is PX1 Research SLU-PP-332 synthesized? A: PX1 Research sources all compounds from state-of-the-art, GMP-compliant manufacturing facilities located within the USA. Synthesized under rigid quality management systems, each batch undergoes strict chemical controls to guarantee reproducible structure and eliminate potential sequence or functional isomers.
Q: How does PX1 Research prevent batch-to-batch variation in small-molecule synthesis? A: Synthetic consistency is preserved using standardized automated synthesis equipment, pure reagent precursors, and controlled crystallization parameters. Every lot undergoes comparative chromatographic profiling against reference standards to ensure structural identity and high inter-batch reproducibility across assay runs.
Q: Are bulk quantities available for institutional research projects? A: Yes. Academic institutions, biotechnology firms, and contract research organizations requiring multi-gram quantities or specialized custom assay configurations can submit procurement inquiries directly through our wholesale lab portal.
Analytical Testing and COA FAQs
Q: How is the purity of SLU-PP-332 verified by PX1 Research? A: Every production lot of SLU-PP-332 is subjected to independent verification by an ISO 17025-accredited laboratory. Testing includes High-Performance Liquid Chromatography (HPLC) to establish chemical purity and Mass Spectrometry (MS) to confirm precise molecular mass.
Q: What is the minimum purity threshold guaranteed by PX1 Research? A: PX1 Research enforces a strict minimum purity spec of ≥98.0% by HPLC area percentage for all batches. Compounds failing to meet this threshold are rejected immediately to protect empirical accuracy in downstream cell assays and invivo screening.
Q: How can researchers access the Certificate of Analysis (COA) for their specific lot? A: Individual lot-specific documentation, including raw HPLC chromatograms and mass spectra, is openly available for inspection through our online COA database. Researchers can cross-reference the batch number printed on the product vial.
Endotoxin Limits and Quality Assurance FAQs
Q: Is SLU-PP-332 tested for bacterial endotoxins and residual contaminants? A: Yes. In addition to HPLC and MS profiling, lots are screened for bacterial endotoxins via Limulus Amebocyte Lysate (LAL) assays. Endotoxin levels are maintained below stringent laboratory thresholds (<0.05 EU/mg) to prevent confounding inflammatory responses in cell cultures.
Q: Are heavy metals or organic solvent residues present in the final product? A: PX1 Research utilizes inductively coupled plasma mass spectrometry (ICP-MS) and gas chromatography (GC) to verify that heavy metals (lead, arsenic, mercury, cadmium) and volatile organic solvents remain well below toxicological detection limits.
Q: Why is third-party verification essential for metabolic research reagents? A: Third-party verification guarantees unbiased assay results by confirming that observed biological responses derive solely from the target molecule rather than synthetic artifacts, cross-contaminants, or degraded byproducts.
Vial Specifications and Formulations FAQs
Q: What physical formats and vial specifications are offered for SLU-PP-332? A: PX1 Research supplies SLU-PP-332 in specialized laboratory formats, including lyophilized powder vials for reconstituted liquid assays and standardized oral solid formats such as SLU-PP-332 capsules (250mcg) for specialized non-human animal feeding studies.
Q: How are lyophilized vials sealed to prevent degradation during storage? A: Powdered reagents are freeze-dried under high vacuum and sealed under an inert nitrogen headspace inside Type I borosilicate glass vials using fluorocarbon-coated butyl stoppers to eliminate moisture ingress and oxidative degradation.
Q: Can solid unit-dose forms be manipulated for lab administration? A: Solid dose formats are formulated for uniform active compound distribution in animal model diets. Researchers requiring precise liquid concentration gradients for microfluidics or cell assays should utilize pure lyophilized powder.
Laboratory Reconstitution and Handling FAQs
Q: What solvents are recommended for reconstituting SLU-PP-332? A: As a lipophilic small molecule, SLU-PP-332 exhibits optimal solubility in organic solvents such as dimethyl sulfoxide (DMSO) or ethanol. Stock solutions can subsequently be diluted into aqueous buffers like phosphate-buffered saline (PBS) containing appropriate co-solvents or surfactants.
Q: How do researchers calculate stock concentrations for cell culture assays? A: Laboratory personnel can calculate solvent volumes, molarities, and working solution concentrations by utilizing our interactive digital reconstitution calculator prior to reconstituting dry compounds.
Q: What steps prevent precipitate formation when diluting organic stock solutions? A: Stock solutions prepared in DMSO should be added slowly, dropwise, into warm aqueous media under continuous agitation. Avoid rapid cold dilution, which may exceed thermodynamic solubility limits and trigger micro-precipitation.
Storage and Stability FAQs
Q: What are the optimal storage conditions for dry powder vials? A: Desiccated, unopened vials of SLU-PP-332 should be stored at -20°C for long-term stability (up to 24 months). For short-term storage (under 30 days), desiccated storage at 4°C is acceptable if protected from ambient light.
Q: How should reconstituted liquid stock solutions be stored? A: Once solubilized in sterile DMSO, stock aliquots should be divided into single-use working volumes and stored at -80°C. Aliquoting minimizes degradation caused by repeated thermal freeze-thaw cycles.
Q: What is the impact of light exposure on SLU-PP-332 stability? A: Like many aromatic small molecules, SLU-PP-332 can undergo photo-oxidation under prolonged exposure to ultraviolet or high-intensity ambient light. Reagents must be kept in amber vials or foil-wrapped containers during handling.
Fulfillment and Shipping Logistics FAQs
Q: What are the standard shipping timelines for PX1 Research orders? A: Orders placed before cutoff times ship same-day from Monday through Friday. Fulfillment originates directly from our centralized distribution facilities situated in California and Arizona to minimize transit times across North America.
Q: How is cold-chain integrity maintained during transit? A: Temperature-sensitive compounds are packed in insulated thermal packaging with specialized ice or cold packs. This preserves chemical stability against ambient heat spikes encountered during regional transport.
Q: Are international shipments covered under standard delivery protocols? A: International transit times vary by customs protocols. PX1 Research provides comprehensive export documentation, commercial invoices, and analytical standard declarations to streamline international laboratory customs clearance.
Preclinical Mechanisms and Comparative Analysis FAQs
Q: What receptor pathways are targeted by SLU-PP-332 in preclinical literature? A: In vitro data indicate that SLU-PP-332 acts as an agonist of ERRα, ERRβ, and ERRγ, promoting downstream transcription of genes involved in fatty acid oxidation and mitochondrial electron transport chain activity.
Q: How does SLU-PP-332 compare to other metabolic research compounds? A: When evaluating cellular energy expenditure pathways, researchers frequently compare SLU-PP-332 against other investigational metabolic agents. In comparative preclinical models, SLU-PP-332 directly targets ERRs, whereas compounds like MOTS-c activate AMPK cascades, and agonists such as SR9009 modulate REV-ERB nuclear receptors.
Q: Where can investigators find published literature on ERR activation mechanisms? A: Researchers seeking deep mechanistic overviews and citations of published animal studies can review peer-reviewed articles indexed within the comprehensive PX1 research hub.
Frequently Asked Questions
What is the certified chemical purity of PX1 Research SLU-PP-332?
PX1 Research guarantees a minimum analytical purity of ≥98.0% by HPLC area percentage for all lots of SLU-PP-332. Each batch undergoes dual HPLC/MS testing at an independent ISO 17025 accredited laboratory.
Is SLU-PP-332 suitable for human clinical applications?
No. SLU-PP-332 is strictly designated for in vitro, cell culture, and non-human preclinical research. It is explicitly prohibited from human, clinical, or veterinary administration.
How should reconstituted SLU-PP-332 stock solutions be stored?
Solubilized stock solutions should be aliquoted into single-use volumes and stored at -80°C. Avoid repeated freeze-thaw cycles to preserve molecular stability and prevent enzymatic or chemical degradation.
What solvent provides optimal solubility for SLU-PP-332?
SLU-PP-332 is lipophilic and dissolves readily in organic solvents such as high-purity DMSO or 100% anhydrous ethanol prior to aqueous buffer dilution.
Where do PX1 Research products ship from?
All orders are fulfilled same-day (Monday–Friday) directly from our state-of-the-art USA distribution centers located in California and Arizona.
Where can I view the Lot-Specific Certificate of Analysis (COA)?
Lot-specific COAs featuring raw HPLC chromatograms, mass spectra, and endotoxin analysis can be accessed anytime via our centralized online COA database using your vial batch number.
What are the primary molecular targets of SLU-PP-332?
Preclinical literature identifies SLU-PP-332 as a potent pan-agonist targeting estrogen-related receptors alpha, beta, and gamma (ERRα, ERRβ, ERRγ).
Does PX1 offer bulk or institutional pricing for research laboratories?
Yes. Qualified academic institutions, biotechnology companies, and principal investigators requiring bulk synthesis or custom lots can request quotes through our wholesale portal.
Related pages
All products are sold strictly for laboratory and research use only. Not for human or veterinary use, diagnosis, treatment or consumption. Statements have not been evaluated by the FDA.